2017 Q4 Form 10-Q Financial Statement

#000120179217000013 Filed on November 07, 2017

View on sec.gov

Income Statement

Concept 2017 Q4 2017 Q3 2016 Q3
Revenue $78.09M $73.28M $73.80M
YoY Change -0.69% -0.71% -3.26%
Cost Of Revenue $28.65M $28.72M $28.36M
YoY Change -4.66% 1.27% -2.78%
Gross Profit $49.44M $44.56M $45.45M
YoY Change 1.77% -1.96% -3.54%
Gross Profit Margin 63.32% 60.81% 61.58%
Selling, General & Admin $31.65M $31.88M $30.26M
YoY Change -2.53% 5.33% -4.46%
% of Gross Profit 64.02% 71.54% 66.59%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $4.620M $4.690M $4.910M
YoY Change -2.94% -4.48% 0.41%
% of Gross Profit 9.34% 10.53% 10.8%
Operating Expenses $36.26M $31.88M $30.26M
YoY Change -2.58% 5.33% -4.46%
Operating Profit $13.18M $7.599M $392.0K
YoY Change 16.02% 1838.52% -96.27%
Interest Expense $140.0K $17.00K $37.00K
YoY Change 1300.0% -54.05% 0.0%
% of Operating Profit 1.06% 0.22% 9.44%
Other Income/Expense, Net
YoY Change
Pretax Income $12.78M $7.616M $429.0K
YoY Change 13.48% 1675.29% -95.93%
Income Tax $5.530M $3.294M $85.00K
% Of Pretax Income 43.28% 43.25% 19.81%
Net Earnings $8.417M $4.366M $326.0K
YoY Change 22.11% 1239.26% -95.18%
Net Earnings / Revenue 10.78% 5.96% 0.44%
Basic Earnings Per Share $0.52 $0.27 $0.02
Diluted Earnings Per Share $0.51 $0.27 $0.02
COMMON SHARES
Basic Shares Outstanding 16.27M shares 16.25M shares 16.07M shares
Diluted Shares Outstanding 16.38M shares 16.23M shares

Balance Sheet

Concept 2017 Q4 2017 Q3 2016 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $179.2M $166.3M $137.7M
YoY Change 22.4% 20.77% 21.0%
Cash & Equivalents $179.2M $166.3M $137.7M
Short-Term Investments
Other Short-Term Assets $4.800M $6.700M $10.40M
YoY Change -9.43% -35.58% -40.91%
Inventory
Prepaid Expenses $4.792M $6.651M $5.553M
Receivables $7.136M $6.389M $5.878M
Other Receivables $0.00 $700.0K $1.200M
Total Short-Term Assets $191.1M $180.1M $155.1M
YoY Change 20.49% 16.06% 9.62%
LONG-TERM ASSETS
Property, Plant & Equipment $95.25M $92.17M $99.16M
YoY Change -2.5% -7.05% -9.74%
Goodwill $33.90M $33.90M $33.90M
YoY Change 0.0% 0.0% -12.26%
Intangibles $4.606M
YoY Change -11.49%
Long-Term Investments $12.48M $14.72M $14.56M
YoY Change -14.58% 1.06% 18.32%
Other Assets $6.276M $9.061M $8.472M
YoY Change -27.83% 6.95% -7.54%
Total Long-Term Assets $147.9M $149.8M $158.2M
YoY Change -5.79% -5.27% -6.93%
TOTAL ASSETS
Total Short-Term Assets $191.1M $180.1M $155.1M
Total Long-Term Assets $147.9M $149.8M $158.2M
Total Assets $339.0M $329.9M $313.3M
YoY Change 7.42% 5.29% 0.59%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $8.844M $5.041M $19.10M
YoY Change 29.05% -73.61% 140.19%
Accrued Expenses $3.621M $13.61M
YoY Change -74.36%
Deferred Revenue $19.37M
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $43.35M $40.65M $43.98M
YoY Change 2.79% -7.58% -23.4%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $43.35M $40.65M $43.98M
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $49.63M $49.88M $56.54M
YoY Change -2.59% -11.78% -23.51%
SHAREHOLDERS EQUITY
Retained Earnings $108.6M $100.2M $80.56M
YoY Change 24.15% 24.33% 23.07%
Common Stock $180.8M $179.9M $176.2M
YoY Change 2.04% 2.07% 2.39%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $289.4M $280.0M $256.8M
YoY Change
Total Liabilities & Shareholders Equity $339.0M $329.9M $313.3M
YoY Change 7.42% 5.29% 0.59%

Cashflow Statement

Concept 2017 Q4 2017 Q3 2016 Q3
OPERATING ACTIVITIES
Net Income $8.417M $4.366M $326.0K
YoY Change 22.11% 1239.26% -95.18%
Depreciation, Depletion And Amortization $4.620M $4.690M $4.910M
YoY Change -2.94% -4.48% 0.41%
Cash From Operating Activities $18.68M $12.99M $13.90M
YoY Change 40.24% -6.55% -30.78%
INVESTING ACTIVITIES
Capital Expenditures -$5.250M $2.754M $2.766M
YoY Change -0.38% -0.43% -59.33%
Acquisitions
YoY Change
Other Investing Activities -$300.0K $0.00 $2.960M
YoY Change -135.71% -100.0% -9966.67%
Cash From Investing Activities -$5.550M -$3.860M -$440.0K
YoY Change 25.57% 777.27% -93.77%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -190.0K 0.000 140.0K
YoY Change -24.0% -100.0% -104.79%
NET CHANGE
Cash From Operating Activities 18.68M 12.99M 13.90M
Cash From Investing Activities -5.550M -3.860M -440.0K
Cash From Financing Activities -190.0K 0.000 140.0K
Net Change In Cash 12.94M 9.130M 13.60M
YoY Change 49.6% -32.87% 34.65%
FREE CASH FLOW
Cash From Operating Activities $18.68M $12.99M $13.90M
Capital Expenditures -$5.250M $2.754M $2.766M
Free Cash Flow $23.93M $10.24M $11.13M
YoY Change 28.73% -8.07% -16.15%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
apei Capitalized Program Development Costs And Other Assets
CapitalizedProgramDevelopmentCostsAndOtherAssets
1464000 USD
apei Capitalized Program Development Costs And Other Assets
CapitalizedProgramDevelopmentCostsAndOtherAssets
3005000 USD
apei Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Amount
EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount
-500000 USD
apei Increase Decrease In Excess Tax Benefit Expense From Share Based Compensation Financing Activities
IncreaseDecreaseInExcessTaxBenefitExpenseFromShareBasedCompensationFinancingActivities
-1002000 USD
apei Increase Decrease In Excess Tax Benefit Expense From Share Based Compensation Financing Activities
IncreaseDecreaseInExcessTaxBenefitExpenseFromShareBasedCompensationFinancingActivities
0 USD
CY2016Q3 apei Instructional Costs And Expenses
InstructionalCostsAndExpenses
28357000 USD
apei Instructional Costs And Expenses
InstructionalCostsAndExpenses
86968000 USD
CY2017Q3 apei Instructional Costs And Expenses
InstructionalCostsAndExpenses
28723000 USD
apei Instructional Costs And Expenses
InstructionalCostsAndExpenses
87513000 USD
apei Number Of Students
NumberOfStudents
86500 student
apei Number Of Subsidiaries
NumberOfSubsidiaries
2 subsidiary
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2017
dei Document Period End Date
DocumentPeriodEndDate
2017-09-30
dei Document Type
DocumentType
10-Q
dei Entity Central Index Key
EntityCentralIndexKey
0001201792
CY2017Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
16267814 shares
dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
dei Entity Registrant Name
EntityRegistrantName
AMERICAN PUBLIC EDUCATION INC
CY2016Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
6853000 USD
CY2017Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
5041000 USD
CY2016Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
6949000 USD
CY2017Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
6389000 USD
CY2016Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
14124000 USD
CY2017Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
13613000 USD
CY2016Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
177061000 USD
CY2017Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
179708000 USD
CY2016Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1255000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
3972000 USD
CY2017Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1566000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
4262000 USD
CY2016Q3 us-gaap Allocated Share Based Compensation Expense Net Of Tax
AllocatedShareBasedCompensationExpenseNetOfTax
751000 USD
us-gaap Allocated Share Based Compensation Expense Net Of Tax
AllocatedShareBasedCompensationExpenseNetOfTax
2406000 USD
CY2017Q3 us-gaap Allocated Share Based Compensation Expense Net Of Tax
AllocatedShareBasedCompensationExpenseNetOfTax
946000 USD
us-gaap Allocated Share Based Compensation Expense Net Of Tax
AllocatedShareBasedCompensationExpenseNetOfTax
2574000 USD
CY2016Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
8077000 USD
CY2017Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
6572000 USD
CY2016Q4 us-gaap Assets
Assets
315620000 USD
CY2017Q3 us-gaap Assets
Assets
329901000 USD
CY2016Q4 us-gaap Assets Current
AssetsCurrent
158627000 USD
CY2017Q3 us-gaap Assets Current
AssetsCurrent
180056000 USD
CY2015Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
105734000 USD
CY2016Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
137691000 USD
CY2016Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
146351000 USD
CY2017Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
166259000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
31957000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
19908000 USD
CY2016Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2017Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2016Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2017Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2016Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
456000 USD
CY2017Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2016Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
16109000 shares
CY2017Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
16249000 shares
CY2016Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
16109000 shares
CY2017Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
16249000 shares
CY2016Q4 us-gaap Common Stock Value
CommonStockValue
161000 USD
CY2017Q3 us-gaap Common Stock Value
CommonStockValue
162000 USD
CY2016Q3 us-gaap Costs And Expenses
CostsAndExpenses
73411000 USD
us-gaap Costs And Expenses
CostsAndExpenses
207492000 USD
CY2017Q3 us-gaap Costs And Expenses
CostsAndExpenses
65680000 USD
us-gaap Costs And Expenses
CostsAndExpenses
198939000 USD
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-1505000 USD
CY2016Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
8775000 USD
CY2017Q3 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
9231000 USD
CY2016Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
20639000 USD
CY2017Q3 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
21994000 USD
CY2016Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
4910000 USD
us-gaap Depreciation And Amortization
DepreciationAndAmortization
14624000 USD
CY2017Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
4690000 USD
us-gaap Depreciation And Amortization
DepreciationAndAmortization
14160000 USD
CY2016Q4 us-gaap Disposal Group Including Discontinued Operation Assets Noncurrent
DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent
2100000 USD
CY2017Q3 us-gaap Disposal Group Including Discontinued Operation Assets Noncurrent
DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent
0 USD
CY2016Q3 us-gaap Disposal Group Not Discontinued Operation Gain Loss On Disposal
DisposalGroupNotDiscontinuedOperationGainLossOnDisposal
-5145000 USD
us-gaap Disposal Group Not Discontinued Operation Gain Loss On Disposal
DisposalGroupNotDiscontinuedOperationGainLossOnDisposal
-5870000 USD
CY2017Q3 us-gaap Disposal Group Not Discontinued Operation Gain Loss On Disposal
DisposalGroupNotDiscontinuedOperationGainLossOnDisposal
-390000 USD
us-gaap Disposal Group Not Discontinued Operation Gain Loss On Disposal
DisposalGroupNotDiscontinuedOperationGainLossOnDisposal
-1558000 USD
CY2016Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.02
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.07
CY2017Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.27
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.78
CY2016Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.02
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.07
CY2017Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.27
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.78
CY2016Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.207
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.379
CY2017Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.430
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.432
CY2016Q3 us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
504000 USD
us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
1566000 USD
CY2017Q3 us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
620000 USD
us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
1688000 USD
CY2016Q4 us-gaap Equity Method Investments
EquityMethodInvestments
14611000 USD
CY2017Q3 us-gaap Equity Method Investments
EquityMethodInvestments
14716000 USD
CY2016Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
17125000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
50703000 USD
CY2017Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
17237000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
51625000 USD
CY2016Q4 us-gaap Goodwill
Goodwill
33899000 USD
CY2017Q3 us-gaap Goodwill
Goodwill
33899000 USD
CY2016Q3 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
4735000 USD
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
4735000 USD
CY2017Q3 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 USD
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 USD
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 USD
CY2016Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
429000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
27133000 USD
CY2017Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
7616000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
22267000 USD
CY2016Q3 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-18000 USD
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
653000 USD
CY2017Q3 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
44000 USD
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
105000 USD
CY2016Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
85000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
10524000 USD
CY2017Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3294000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
9668000 USD
us-gaap Income Taxes Paid
IncomeTaxesPaid
14894000 USD
us-gaap Income Taxes Paid
IncomeTaxesPaid
10528000 USD
CY2016Q4 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
0 USD
CY2017Q3 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
757000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-617000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-1812000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-2039000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-560000 USD
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-682000 USD
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-559000 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-1492000 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-1430000 USD
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-370000 USD
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
1355000 USD
us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
1182000 USD
us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
757000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-677000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1445000 USD
CY2016Q3 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
37000 USD
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
111000 USD
CY2017Q3 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
17000 USD
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
43000 USD
CY2016Q4 us-gaap Liabilities
Liabilities
50950000 USD
CY2017Q3 us-gaap Liabilities
Liabilities
49879000 USD
CY2016Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
315620000 USD
CY2017Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
329901000 USD
CY2016Q4 us-gaap Liabilities Current
LiabilitiesCurrent
42175000 USD
CY2017Q3 us-gaap Liabilities Current
LiabilitiesCurrent
40648000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-1604000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-1304000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-9127000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-8047000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
42688000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
29259000 USD
CY2016Q3 us-gaap Net Income Loss
NetIncomeLoss
326000 USD
us-gaap Net Income Loss
NetIncomeLoss
17262000 USD
CY2017Q3 us-gaap Net Income Loss
NetIncomeLoss
4366000 USD
us-gaap Net Income Loss
NetIncomeLoss
12704000 USD
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
2 segment
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2 segment
CY2016Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
392000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
27022000 USD
CY2017Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
7599000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
22224000 USD
CY2016Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
8696000 USD
CY2017Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
9061000 USD
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-10000 USD
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-312000 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
630000 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
1404000 USD
us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
950000 USD
us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
0 USD
CY2016Q3 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2766000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
9670000 USD
CY2017Q3 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2754000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
6535000 USD
CY2016Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2017Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2016Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2017Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2016Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2017Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2016Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2017Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2016Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2017Q3 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2016Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
5327000 USD
CY2017Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
6651000 USD
us-gaap Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital
ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital
2957000 USD
us-gaap Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital
ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital
0 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
28000 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
100000 USD
us-gaap Proceeds From Sale Of Buildings
ProceedsFromSaleOfBuildings
0 USD
us-gaap Proceeds From Sale Of Buildings
ProceedsFromSaleOfBuildings
1493000 USD
CY2017Q3 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
2200000 USD
CY2016Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
87448000 USD
CY2017Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
100152000 USD
CY2016Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
97687000 USD
CY2017Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
92169000 USD
CY2016Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
1600000 USD
CY2016Q3 us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
73803000 USD
us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
234514000 USD
CY2017Q3 us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
73279000 USD
us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
221163000 USD
CY2016Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
13139000 USD
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
44592000 USD
CY2017Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
14640000 USD
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
44083000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
3972000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
4262000 USD
CY2017Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
113616 shares
CY2017Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
37.52
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
132351 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0 shares
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
246000 USD
CY2017Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
0 USD
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
259969 shares
CY2017Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
113616 shares
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
34.68
CY2017Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
37.52
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
6.99
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
35.17
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0.00
CY2017Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
0 USD
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P3M3D
CY2016 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6M12D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P3M3D
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
14002 shares
CY2016Q4 us-gaap Stockholders Equity
StockholdersEquity
264670000 USD
CY2017Q3 us-gaap Stockholders Equity
StockholdersEquity
280022000 USD
CY2016Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
559000 USD
CY2017Q3 us-gaap Taxes Payable Current
TaxesPayableCurrent
0 USD
CY2016Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
16233229 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
16174723 shares
CY2017Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
16375512 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
16351563 shares
CY2016Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
16074701 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
16057710 shares
CY2017Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
16248623 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
16225869 shares
us-gaap Nature Of Operations
NatureOfOperations
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Nature of the Business</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">American Public Education, Inc., or APEI, which together with its subsidiaries is referred to as the &#8220;Company,&#8221; is a provider of online and campus-based postsecondary education to approximately </font><font style="font-family:inherit;font-size:10pt;">86,500</font><font style="font-family:inherit;font-size:10pt;"> students through the operations of </font><font style="font-family:inherit;font-size:10pt;">two</font><font style="font-family:inherit;font-size:10pt;"> subsidiary institutions:</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">American Public University System, Inc., or APUS, provides online postsecondary education directed primarily at the needs of the military and public safety communities through American Military University, or AMU, and American Public University, or APU.&#160;APUS is regionally accredited by the Higher Learning Commission.</font></div></td></tr></table><div style="line-height:120%;text-align:left;padding-left:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">National Education Seminars, Inc., which is referred to herein as Hondros College of Nursing, or HCN,&#160;provides nursing education to students at </font><font style="font-family:inherit;font-size:10pt;">five</font><font style="font-family:inherit;font-size:10pt;"> campuses in the State of Ohio as well as online to serve the needs of the nursing and healthcare communities.&#160;HCN is nationally accredited by the Accrediting Council of Independent Colleges and Schools, or ACICS, and the RN-to-BSN Program is accredited by the Commission on Collegiate Nursing Education. In June 2016, HCN was notified that its Diploma in Practical Nursing and Associates Degree in Nursing Programs have been granted pre-accreditation candidacy status by the National League for Nursing Commission for Nursing Education Accreditation. </font></div></td></tr></table><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company&#8217;s institutions are licensed or otherwise authorized, or are in the process of obtaining such licenses or authorizations, to offer postsecondary education programs by state authorities to the extent the institutions believe such licenses or authorizations are required, and are certified by the United States Department of Education, or ED, to participate in student financial aid programs authorized under Title IV of the Higher Education Act of 1965, as amended, or Title IV programs.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company&#8217;s operations are organized into </font><font style="font-family:inherit;font-size:10pt;">two</font><font style="font-family:inherit;font-size:10pt;"> reportable segments:</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">American Public Education Segment, or APEI Segment.</font><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;"> </font><font style="font-family:inherit;font-size:10pt;">This segment reflects the operational activities at APUS, other corporate activities, and minority investments.</font></div></td></tr></table><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;" rowspan="1" colspan="1"></td><td rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:top" rowspan="1" colspan="1"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:inherit;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;" rowspan="1" colspan="1"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Hondros College of Nursing Segment, or HCN Segment.</font><font style="font-family:inherit;font-size:10pt;">&#160;This segment reflects the operational activities of HCN.</font></div></td></tr></table></div>
us-gaap Use Of Estimates
UseOfEstimates
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;text-indent:12px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Use of Estimates</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The preparation of the Consolidated Financial Statements in accordance with GAAP requires management to make estimates and assumptions that affect the reported amounts in these unaudited interim Consolidated Financial Statements and accompanying notes. Actual results could differ from those estimates.</font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></div>

Files In Submission

Name View Source Status
0001201792-17-000013-index-headers.html Edgar Link pending
0001201792-17-000013-index.html Edgar Link pending
0001201792-17-000013.txt Edgar Link pending
0001201792-17-000013-xbrl.zip Edgar Link pending
apei-20170930.xml Edgar Link completed
apei-20170930.xsd Edgar Link pending
apei-20170930_cal.xml Edgar Link unprocessable
apei-20170930_def.xml Edgar Link unprocessable
apei-20170930_lab.xml Edgar Link unprocessable
apei-20170930_pre.xml Edgar Link unprocessable
apeiq30930201710q.htm Edgar Link pending
exhibit101image1.jpg Edgar Link pending
exhibit101_3q17.htm Edgar Link pending
exhibit311_q317.htm Edgar Link pending
exhibit312_q317.htm Edgar Link pending
exhibit321_q317.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
image0a08.jpg Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending